{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T09:54:51Z","timestamp":1742378091771},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,17]]},"DOI":"10.7759\/cureus.47200","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T12:49:41Z","timestamp":1697546981000},"source":"Crossref","is-referenced-by-count":2,"title":["Anti-M\u00fcllerian Hormone: A Predictor of Successful Intrauterine Insemination"],"prefix":"10.7759","author":[{"given":"Allison","family":"Stalzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dara","family":"Seybold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pickens","family":"Gantt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Broce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Cronkright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0331","article-title":"Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation","volume":"91","author":"Hehenkamp WJ","year":"2006","unstructured":"Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-M\u00fcllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab. 2006, 91:4057-63. 10.1210\/jc.2006-0331","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.12.006","article-title":"Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve","volume":"113","author":"Tiegs AW","year":"2020","unstructured":"Tiegs AW, Sun L, Scott RT Jr, Goodman LR. Comparison of pregnancy outcomes following intrauterine insemination in young women with decreased versus normal ovarian reserve. Fertil Steril. 2020, 113:788-796.e4. 10.1016\/j.fertnstert.2019.12.006","journal-title":"Fertil Steril"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.595448","article-title":"Relationship between anti-M\u00fcllerian hormone and in vitro fertilization-embryo transfer in clinical pregnancy","volume":"11","author":"Sun XY","year":"2020","unstructured":"Sun XY, Lan YZ, Liu S, Long XP, Mao XG, Liu L. Relationship between anti-M\u00fcllerian hormone and in vitro fertilization-embryo transfer in clinical pregnancy. Front Endocrinol (Lausanne). 2020, 11:10.3389\/fendo.2020.595448","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2014.07.029","article-title":"AMH: An ovarian reserve biomarker in assisted reproduction","volume":"437","author":"Peluso C","year":"2014","unstructured":"Peluso C, Fonseca FL, Rodart IF, et al.. AMH: An ovarian reserve biomarker in assisted reproduction. Clin Chim Acta. 2014, 437:175-82. 10.1016\/j.cca.2014.07.029","journal-title":"Clin Chim Acta"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/17.12.3065","article-title":"Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve","volume":"17","author":"van Rooij IA","year":"2002","unstructured":"van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP. Serum anti-M\u00fcllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002, 17:3065-71. 10.1093\/humrep\/17.12.3065","journal-title":"Hum Reprod"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.07.1293","article-title":"Evaluation of anti-M\u00fcllerian hormone as a test for the prediction of ovarian reserve","volume":"90","author":"Kwee J","year":"2008","unstructured":"Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-M\u00fcllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril. 2008, 90:737-43. 10.1016\/j.fertnstert.2007.07.1293","journal-title":"Fertil Steril"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2010.04.067","article-title":"Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve","volume":"94","author":"Gleicher N","year":"2010","unstructured":"Gleicher N, Weghofer A, Barad DH. Anti-M\u00fcllerian hormone (AMH) defines, independent of age, low versus good live-birth chances in women with severely diminished ovarian reserve. Fertil Steril. 2010, 94:2824-7. 10.1016\/j.fertnstert.2010.04.067","journal-title":"Fertil Steril"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(01)03201-0","article-title":"Early follicular serum M\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles","volume":"77","author":"Seifer DB","year":"2002","unstructured":"Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM. Early follicular serum M\u00fcllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril. 2002, 77:468-71. 10.1016\/s0015-0282(01)03201-0","journal-title":"Fertil Steril"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2005.00670.x","article-title":"Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?","volume":"112","author":"Muttukrishna S","year":"2005","unstructured":"Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. BJOG. 2005, 112:1384-90. 10.1111\/j.1471-0528.2005.00670.x","journal-title":"BJOG"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.09.019","article-title":"Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve","volume":"85","author":"Fi\u00e7icioglu C","year":"2006","unstructured":"Fi\u00e7icioglu C, Kutlu T, Baglam E, Bakacak Z. Early follicular antim\u00fcllerian hormone as an indicator of ovarian reserve. Fertil Steril. 2006, 85:592-6. 10.1016\/j.fertnstert.2005.09.019","journal-title":"Fertil Steril"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/den108","article-title":"Relevance of anti-Mullerian hormone measurement in a routine IVF program","volume":"23","author":"Gnoth C","year":"2008","unstructured":"Gnoth C, Schuring AN, Friol K, Tigges J, Mallmann P, Godehardt E. Relevance of anti-Mullerian hormone measurement in a routine IVF program. Hum Reprod. 2008, 23:1359-65. 10.1093\/humrep\/den108","journal-title":"Hum Reprod"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh718","article-title":"Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment","volume":"20","author":"Pe\u00f1arrubia J","year":"2005","unstructured":"Pe\u00f1arrubia J, F\u00e1bregues F, Manau D, et al.. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Hum Reprod. 2005, 20:915-22. 10.1093\/humrep\/deh718","journal-title":"Hum Reprod"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.08.021","article-title":"Anti-M\u00fcllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination","volume":"133","author":"Moro F","year":"2016","unstructured":"Moro F, Tropea A, Scarinci E, et al.. Anti-M\u00fcllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination. Int J Gynaecol Obstet. 2016, 133:64-8. 10.1016\/j.ijgo.2015.08.021","journal-title":"Int J Gynaecol Obstet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.3.698","article-title":"Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome","volume":"14","author":"Nuojua-Huttunen S","year":"1999","unstructured":"Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod. 1999, 14:698-703. 10.1093\/humrep\/14.3.698","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.12.059","article-title":"Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination","volume":"94","author":"Li HW","year":"2010","unstructured":"Li HW, Yeung WS, Lau EY, Ho PC, Ng EH. Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine insemination. Fertil Steril. 2010, 94:2177-81. 10.1016\/j.fertnstert.2009.12.059","journal-title":"Fertil Steril"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2010.01232.x","article-title":"Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy","volume":"50","author":"Tremellen K","year":"2010","unstructured":"Tremellen K, Kolo M. Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy. Aust N Z J Obstet Gynaecol. 2010, 50:568-72. 10.1111\/j.1479-828X.2010.01232.x","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.02.007","article-title":"Prospective investigation of serum anti-M\u00fcllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study","volume":"20","author":"Freiesleben Nl","year":"2010","unstructured":"Freiesleben Nl, Rosendahl M, Johannsen TH, et al.. Prospective investigation of serum anti-M\u00fcllerian hormone concentration in ovulatory intrauterine insemination patients: a preliminary study. Reprod Biomed Online. 2010, 20:582-7. 10.1016\/j.rbmo.2010.02.007","journal-title":"Reprod Biomed Online"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/uog.2633","article-title":"Evaluation and validation of a new risk score (CLEOPATRA score) to predict the probability of premature delivery for patients with threatened preterm labor","volume":"26","author":"Tekesin I","year":"2005","unstructured":"Tekesin I, Eberhart LH, Schaefer V, Wallwiener D, Schmidt S. Evaluation and validation of a new risk score (CLEOPATRA score) to predict the probability of premature delivery for patients with threatened preterm labor. Ultrasound Obstet Gynecol. 2005, 26:699-706. 10.1002\/uog.2633","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/JCMA.0000000000000023","article-title":"The role of anti-M\u00fcllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination","volume":"82","author":"Seckin B","year":"2019","unstructured":"Seckin B, Tokmak A, Yumusak OH. The role of anti-M\u00fcllerian hormone in prediction of pregnancy in young and older women with unexplained infertility undergoing intrauterine insemination. J Chin Med Assoc. 2019, 82:300-4. 10.1097\/JCMA.0000000000000023","journal-title":"J Chin Med Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2017.01.029","article-title":"The value of anti-M\u00fcllerian hormone in predicting clinical pregnancy after intrauterine insemination","volume":"39","author":"Dondik Y","year":"2017","unstructured":"Dondik Y, Virji N, Butler TS, Gaskins JT, Pagidas K, Sung L. The value of anti-M\u00fcllerian hormone in predicting clinical pregnancy after intrauterine insemination. J Obstet Gynaecol Can. 2017, 39:880-5. 10.1016\/j.jogc.2017.01.029","journal-title":"J Obstet Gynaecol Can"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey238","article-title":"Diminished ovarian reserve and poor response to stimulation in patients &lt;38 years old: a quantitative but not qualitative reduction in performance","volume":"33","author":"Morin SJ","year":"2018","unstructured":"Morin SJ, Patounakis G, Juneau CR, Neal SA, Scott RT, Seli E. Diminished ovarian reserve and poor response to stimulation in patients &amp;lt;38 years old: a quantitative but not qualitative reduction in performance. Hum Reprod. 2018, 33:1489-98. 10.1093\/humrep\/dey238","journal-title":"Hum Reprod"},{"key":"ref22","article-title":"Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility","volume":"53","author":"Randall GW","year":"2008","unstructured":"Randall GW, Gantt PA. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility. J Reprod Med. 2008, 53:196-202.","journal-title":"J Reprod Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05899-3","article-title":"\u03b2-Edorphin predict pregnancy outcome of PCOS and DOR women after IVF-ET","volume":"303","author":"Zhang C","year":"2021","unstructured":"Zhang C, Liu S, Liu G, He Y, Wang Y, Wang F. \u03b2-Edorphin predict pregnancy outcome of PCOS and DOR women after IVF-ET. Arch Gynecol Obstet. 2021, 303:1207-16. 10.1007\/s00404-020-05899-3","journal-title":"Arch Gynecol Obstet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76543-y","article-title":"AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles","volume":"10","author":"Dai X","year":"2020","unstructured":"Dai X, Wang Y, Yang H, et al.. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF\/ICSI cycles. Sci Rep. 2020, 10:19750. 10.1038\/s41598-020-76543-y","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden WJ","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950, 3:32-5. 10.1002\/1097-0142(1950)3:1&lt;32::aid-cncr2820030106&gt;3.0.co;2-3","journal-title":"Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.09.041","article-title":"Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis","volume":"103","author":"Tal R","year":"2015","unstructured":"Tal R, Tal O, Seifer BJ, Seifer DB. Antim\u00fcllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril. 2015, 103:119-30.e3. 10.1016\/j.fertnstert.2014.09.041","journal-title":"Fertil Steril"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1025381","article-title":"Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?","volume":"31","author":"Bakas P","year":"2015","unstructured":"Bakas P, Boutas I, Creatsa M, Vlahos N, Gregoriou O, Creatsas G, Hassiakos D. Can anti-Mullerian hormone (AMH) predict the outcome of intrauterine insemination with controlled ovarian stimulation?. Gynecol Endocrinol. 2015, 31:765-8. 10.3109\/09513590.2015.1025381","journal-title":"Gynecol Endocrinol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.repbio.2014.03.004","article-title":"Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology","volume":"14","author":"Lukaszuk K","year":"2014","unstructured":"Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E. Anti-M\u00fcllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol. 2014, 14:176-81. 10.1016\/j.repbio.2014.03.004","journal-title":"Reprod Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/188262-anti-mllerian-hormone-a-predictor-of-successful-intrauterine-insemination","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:59Z","timestamp":1707508439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/188262-anti-mllerian-hormone-a-predictor-of-successful-intrauterine-insemination"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.47200","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,17]]}}}